Merck · 4 days ago
MRL IT Associate Investment Manager, Digital Solutions Product Lines (Hybrid - MA, NJ or PA)
Merck is a leading global healthcare company, and they are seeking an IT Associate Investment Manager to assist in IT investment management and value realization activities across product lines. The role involves supporting financial stewardship and governance processes by preparing data, maintaining records, and transforming information into actionable summaries.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Gather and validate financial data from Apptio and other systems
Assist in maintaining business cases through governance stages (concept, approval, execution, closeout)
Prepare pre-read materials and ensure completeness for capital governance checkpoints
Update forecasts, reconcile actuals, and check coding accuracy in dependent systems
Support variance analysis and document findings for senior team members
Track progress on value realization activities and maintain dashboards or trackers
Create simple visuals and summaries for stakeholder communication
Qualification
Required
High School Diploma required. Advanced degree preferred
Minimum of 1 year of experience in financial management, data analysis, or IT project management
Proficiency in Excel; familiarity with Power BI or similar tools is a plus
Detail-oriented with strong organizational skills and ability to meet deadlines
Interest in learning financial governance and IT investment processes
Strong communication skills with ability to present information clearly
Exposure to SAP/Ariba or Apptio is helpful but not required
Benefits
Medical, dental, vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase